Groowe Groowe / Newsroom / QTRX
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

QTRX News

Quanterix Corporation Common Stock

Quanterix To Report First Quarter 2026 Financial Results on May 6, 2026

businesswire.com
QTRX

Quanterix Debuts Content Innovation Engine at AACR 2026

businesswire.com
QTRX

Quanterix Corporation Announces Date of 2026 Annual Meeting

businesswire.com
QTRX

Quotient Therapeutics Announces Collaboration with Merck to Discover Novel Drug Targets in Inflammatory Bowel Disease Using Somatic Genomics Platform Technology

globenewswire.com
MRK QTRX

Nanotechnology Market Research Report 2026-2030: Strategic Initiatives by Industry Leaders and Emerging Nano-Sensor, Composite and Precision Tool Technologies Shape Future Growth

globenewswire.com
MMM AMAT BRKR DD DV ESP FSLR GEHC HPE HON IBM INTC KMB MSFT NOC NVDA QCOM QTRX RIVN S SAN SAP SMCI SNPS SPWR T TEL TER TGT TMO TSM TXN VRSN WD

Quanta Therapeutics Presents Preclinical Data Establishing that Direct Multi-KRAS Inhibitors Retain Strong Activity Against Resistance Mechanisms Acquired from Treatment with pan-RAS Tri-Complex Inhibitors

globenewswire.com
QTRX

Quell Therapeutics Demonstrates Safety, Phenotypic Stability, Durability and Early Efficacy with Phenotype‑Locked™ CAR‑Tregs in LIBERATE Phase 1/2 Liver Transplant Study

globenewswire.com
QTRX

Form 8-K

sec.gov
QTRX

Quanterix Releases Financial Results for the Fourth Quarter and Full Year 2025

businesswire.com
QTRX

Lucent Diagnostics and Life Line Screening Partner to Bring Advanced Blood-Based Diagnostics to Communities Nationwide

businesswire.com
QTRX